Capital International Investors

Position in ABBV — AbbVie Inc.

CIK 1562230 Los Angeles, CA

Back to ABBV Full portfolio

Position in ABBV

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,135,986,787

+$464,306,913 QoQ

Shares Held

14,418,993

+23.3% QoQ

Ownership

0.816%

of shares outstanding

% of Portfolio

0.79%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.4621399705236.ToString("F0")% Shared 0.ToString("F0")% None 0.5378600294763997.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Capital International Investors holds $19,740,296,250 across 8 Drug Manufacturers - General names. ABBV ranks #3 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	34,393,013	$6,782,990,023
2	LLY	ELI LILLY & Co	6,116,692	$5,625,949,800
3	ABBV	AbbVie Inc. This page	14,418,993	$3,135,986,787
4	AMGN	Amgen Inc	7,122,275	$2,505,972,458
5	JNJ	Johnson & Johnson	2,617,363	$639,788,211
6	BMY	Bristol Myers Squibb Co	8,432,445	$511,427,789
7	NVO	Novo Nordisk A S	11,795,850	$433,497,487
8	MRK	Merck & Co., Inc.	870,261	$104,683,695

All Filings in ABBV

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,135,986,787	14,418,993	+23.3%	Shares	Defined	2026-05-13
2025-12-31	$2,671,679,874	11,692,765	+9.2%	Shares	Defined	2026-02-11
2025-09-30	$2,478,295,799	10,703,532	-21.6%	Shares	Defined	2025-11-13
2025-06-30	$2,533,976,951	13,651,422	-33.5%	Shares	Defined	2025-08-13
2025-03-31	$4,302,855,669	20,536,730	-28.0%	Shares	Defined	2025-05-12
2024-12-31	$5,070,400,817	28,533,488	-22.4%	Shares	Defined	2025-02-13
2024-09-30	$7,264,863,433	36,787,844	-4.7%	Shares	Defined	2024-11-13
2024-06-30	$6,621,046,599	38,602,184	-19.7%	Shares	Defined	2024-08-13
2024-03-31	$8,758,788,566	48,098,784	+6.9%	Shares	Defined	2024-05-14
2023-12-31	$6,971,818,719	44,988,183	+6.0%	Shares	Defined	2024-02-13
2023-09-30	$6,326,959,023	42,445,720	-1.6%	Shares	Defined	2023-11-13
2023-06-30	$5,813,968,794	43,152,741	+0.9%	Shares	Defined	2023-08-11
2023-03-31	$6,812,806,451	42,748,362	-9.2%	Shares	Defined	2023-05-15
2022-12-31	$7,611,605,877	47,098,607	+2.8%	Shares	Defined	2023-02-14
2022-09-30	$6,150,476,296	45,827,258	+6.2%	Shares	Defined	2022-11-14
2022-06-30	$6,609,638,332	43,155,121	+41.5%	Shares	Defined	2022-08-15
2022-03-31	$4,943,993,008	30,497,767	+162.6%	Shares	Defined	2022-05-19
2021-12-31	$1,572,680,207	11,615,068	+19.7%	Shares	Defined	2022-02-14
2021-09-30	$1,046,513,425	9,701,617	+0.0%	Shares	Defined	2021-11-15
2021-06-30	$1,092,459,653	9,698,683	-0.0%	Shares	Defined	2021-08-16
2021-03-31	$1,049,736,597	9,700,024	+23.2%	Shares	Defined	2021-05-14
2020-12-31	$843,444,190	7,871,621	-21.3%	Shares	Defined	2021-02-12
2020-09-30	$875,558,399	9,996,100	-13.0%	Shares	Defined	2020-11-13
2020-06-30	$1,128,034,201	11,489,450	+44.1%	Shares	Defined	2020-08-14
2020-03-31	$607,496,850	7,973,446	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.